These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26339766)

  • 1. The mast cell as a pluripotent HDL-modifying effector in atherogenesis: from in vitro to in vivo significance.
    Lee-Rueckert M; Kovanen PT
    Curr Opin Lipidol; 2015 Oct; 26(5):362-8. PubMed ID: 26339766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport.
    Lee-Rueckert M; Kovanen PT
    Atherosclerosis; 2006 Nov; 189(1):8-18. PubMed ID: 16530202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mast cell-dependent proteolytic modification of HDL particles during anaphylactic shock in the mouse reduces their ability to induce cholesterol efflux from macrophage foam cells ex vivo.
    Judström I; Jukkola H; Metso J; Jauhiainen M; Kovanen PT; Lee-Rueckert M
    Atherosclerosis; 2010 Jan; 208(1):148-54. PubMed ID: 19679305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mast cell--a potential link between inflammation and cellular cholesterol deposition in atherogenesis.
    Kovanen PT
    Eur Heart J; 1993 Dec; 14 Suppl K():105-17. PubMed ID: 8131778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular modifications of HDL in vivo and the emerging concept of proteolytic inactivation of preβ-HDL.
    Lee-Rueckert M; Kovanen PT
    Curr Opin Lipidol; 2011 Oct; 22(5):394-402. PubMed ID: 21881503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
    Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
    Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chymase in exocytosed rat mast cell granules effectively proteolyzes apolipoprotein AI-containing lipoproteins, so reducing the cholesterol efflux-inducing ability of serum and aortic intimal fluid.
    Lindstedt L; Lee M; Castro GR; Fruchart JC; Kovanen PT
    J Clin Invest; 1996 May; 97(10):2174-82. PubMed ID: 8636396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced vascular permeability facilitates entry of plasma HDL and promotes macrophage-reverse cholesterol transport from skin in mice.
    Kareinen I; Cedó L; Silvennoinen R; Laurila PP; Jauhiainen M; Julve J; Blanco-Vaca F; Escola-Gil JC; Kovanen PT; Lee-Rueckert M
    J Lipid Res; 2015 Feb; 56(2):241-53. PubMed ID: 25473102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol.
    Lee M; Sommerhoff CP; von Eckardstein A; Zettl F; Fritz H; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2002 Dec; 22(12):2086-91. PubMed ID: 12482839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell-mediated inhibition of reverse cholesterol transport.
    Lee M; Lindstedt LK; Kovanen PT
    Arterioscler Thromb; 1992 Nov; 12(11):1329-35. PubMed ID: 1420092
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin and kallikrein reduce HDL-induced cholesterol efflux from foam cells.
    Lindstedt L; Kovanen PT
    Biochem Biophys Res Commun; 2000 Nov; 277(3):552-7. PubMed ID: 11061992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDLs, immunity, and atherosclerosis.
    Norata GD; Pirillo A; Catapano AL
    Curr Opin Lipidol; 2011 Oct; 22(5):410-6. PubMed ID: 21881500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of mast cell granules.
    Lindstedt KA; Kovanen PT
    Curr Protoc Cell Biol; 2006 Jan; Chapter 3():Unit 3.16. PubMed ID: 18228484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mast cells: multipotent local effector cells in atherothrombosis.
    Kovanen PT
    Immunol Rev; 2007 Jun; 217():105-22. PubMed ID: 17498055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast cells in atherosclerotic cardiovascular disease - Activators and actions.
    Kovanen PT; Bot I
    Eur J Pharmacol; 2017 Dec; 816():37-46. PubMed ID: 29032103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein metabolism and endothelial function.
    Lowenstein CJ; Cameron SJ
    Curr Opin Endocrinol Diabetes Obes; 2010 Apr; 17(2):166-70. PubMed ID: 20125006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of mast cells in atherosclerosis.
    Kovanen PT
    Chem Immunol; 1995; 62():132-70. PubMed ID: 7546279
    [No Abstract]   [Full Text] [Related]  

  • 18. Mast cells in atherosclerosis.
    Bot I; Biessen EA
    Thromb Haemost; 2011 Nov; 106(5):820-6. PubMed ID: 21866302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The metabolism of low density lipoproteins by rat serosal mast cells.
    Kokkonen JO; Kovanen PT
    Eur Heart J; 1990 Aug; 11 Suppl E():134-46. PubMed ID: 2226522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of gender and serum estradiol levels on HDL-mediated reverse cholesterol transport.
    Badeau RM; Metso J; Kovanen PT; Lee-Rueckert M; Tikkanen MJ; Jauhiainen M
    Eur J Clin Invest; 2013 Apr; 43(4):317-23. PubMed ID: 23397902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.